Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

911 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Efficacy of a brief cognitive behavioral therapy for head and neck cancer survivors with body image distress: secondary outcomes from the BRIGHT pilot randomized clinical trial.
Graboyes EM, Kistner-Griffin E, Hill EG, Maurer S, Balliet W, Williams AM, Padgett L, Yan F, Rush A, Johnson B, McLeod T, Dahne J, Ruggiero KJ, Sterba KR. Graboyes EM, et al. Among authors: rush a. J Cancer Surviv. 2023 Aug 29:10.1007/s11764-023-01454-6. doi: 10.1007/s11764-023-01454-6. Online ahead of print. J Cancer Surviv. 2023. PMID: 37644354
Efficacy of a Brief Tele-Cognitive Behavioral Treatment vs Attention Control for Head and Neck Cancer Survivors With Body Image Distress: A Pilot Randomized Clinical Trial.
Graboyes EM, Maurer S, Balliet W, Li H, Williams AM, Osazuwa-Peters N, Yan F, Padgett L, Rush A, Ruggiero KJ, Sterba KR. Graboyes EM, et al. Among authors: rush a. JAMA Otolaryngol Head Neck Surg. 2023 Jan 1;149(1):54-62. doi: 10.1001/jamaoto.2022.3700. JAMA Otolaryngol Head Neck Surg. 2023. PMID: 36454561 Free PMC article. Clinical Trial.
Alternative metrics for characterizing longer-term clinical outcomes in difficult-to-treat depression: I. Association with change in quality of life.
Sackeim HA, Rush AJ, Greco T, Jiang M, Badejo S, Bunker MT, Aaronson ST, Conway CR, Demyttenaere K, Young AH, McAllister-Williams RH. Sackeim HA, et al. Among authors: rush aj. Psychol Med. 2023 Jan 5;53(14):1-13. doi: 10.1017/S0033291722003798. Online ahead of print. Psychol Med. 2023. PMID: 36601813 Free PMC article.
Metabolomics Signatures of serotonin reuptake inhibitor (Escitalopram), serotonin norepinephrine reuptake inhibitor (Duloxetine) and Cognitive Behavior Therapy on Key Neurotransmitter Pathways in Major Depressive Disorder.
Bhattacharyya S, MahmoudianDehkordi S, Sniatynski MJ, Belenky M, Marur VR, Rush AJ, Craighead WE, Mayberg HS, Dunlop BW, Kristal BS, Kaddurah-Daouk R; Mood Disorder Precision Medicine Consortium. Bhattacharyya S, et al. Among authors: rush aj. medRxiv [Preprint]. 2024 Apr 3:2024.04.02.24304677. doi: 10.1101/2024.04.02.24304677. medRxiv. 2024. PMID: 38633777 Free PMC article. Preprint.
Clinical characteristics and treatment exposure of patients with marked treatment-resistant unipolar major depressive disorder: A RECOVER trial report.
Conway CR, Aaronson ST, Sackeim HA, Duffy W, Stedman M, Quevedo J, Allen RM, Riva-Posse P, Berger MA, Alva G, Malik MA, Dunner DL, Cichowicz I, Luing H, Zajecka J, Nahas Z, Mickey BJ, Kablinger AS, Kriedt CL, Bunker MT, Lee YL, Shy O, Majewski S, Olin B, Tran Q, Rush AJ. Conway CR, et al. Among authors: rush aj. Brain Stimul. 2024 Mar-Apr;17(2):448-459. doi: 10.1016/j.brs.2024.03.016. Epub 2024 Apr 2. Brain Stimul. 2024. PMID: 38574853 Free article. Clinical Trial.
911 results